Tag Archives: south africa

TBDx™ Activities and Continuing Progress: A Quick Snapshot

Applied Visual Sciences, Inc. (APVS.OB) Over the past several months TBDx has been engaged in evaluations in several countries or has been involved in the publication of those results. Here is a quick update: The results from the TBDx evaluation … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , , , , ,

South Africa Evaluation Manuscript Officially Accepted for Publication by AJRCCM

This morning Dr. Nazir Ismail, Director of the Center for Tuberculosis in Johannesburg, received word from the editor of the American Journal of Respiratory and Critical Care Medicine (AJRCCM) accepting the article that presents the analysis of the TBDx™ evaluation … Continue reading

Posted in Healthcare, TB | Tagged , , , , , , , , , , , , | 1 Comment

FIND and APVS Launch TBDx™ Feasibility Evaluation in Peru

The mission of the Foundation for Innovative New Diagnostics (FIND) is to assist in the development and deployment of accurate and affordable diagnostic tests for poverty-related diseases in developing countries. In March, FIND and APVS entered into a collaboration agreement … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , , , , , , , , , , ,

2014 – 3rd Quarter Business Update

“Success is not final; failure is not fatal. It is the courage to continue that counts.”     Winston Churchill Let’s get the lone negative out-of-the-way – the investment catalyst that we anticipated would occur during the 3rd quarter did not occur.  … Continue reading

Posted in Corporate, Healthcare, TB | Tagged , , , , , , , , , , , , , , , , ,

TBDx in Africa – Times Two!

Earlier this month, APVS staff visited the two sites in Africa where TBDx™ technology is currently installed and operational.  In addition to performing system checks and maintenance, this was an opportunity to interact with the key stakeholders, to observe the … Continue reading

Posted in Healthcare, TB | Tagged , , , , , , , | 1 Comment